These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
722 related articles for article (PubMed ID: 25596994)
21. Caspase 3 as a Novel Marker to Distinguish Chromophobe Renal Cell Carcinoma from Oncocytoma. Kowalewski A; Szylberg Ł; Tyloch J; Antosik P; Neska-Długosz I; Frąckowski Ł; Tyloch D; Purpurowicz P; Grzanka D Pathol Oncol Res; 2019 Oct; 25(4):1519-1524. PubMed ID: 30467700 [TBL] [Abstract][Full Text] [Related]
22. Typing of renal tumors by morphological and immunocytochemical evaluation of fine needle aspirates. Strojan Fležar M; Gutnik H; Jeruc J; Kirbiš IS Virchows Arch; 2011 Dec; 459(6):607-14. PubMed ID: 22052200 [TBL] [Abstract][Full Text] [Related]
24. [Diagnostic utility of immunohistochemistry in differential diagnosis of renal tumors with oncocytic features]. Zhang W; Yu WJ; Chen YQ; Kang EH; Liu Y; Zhuang J; Jiang YX; Chu J; Li YJ Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):692-697. PubMed ID: 27760610 [No Abstract] [Full Text] [Related]
25. Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Garcia E; Li M Am J Clin Pathol; 2006 Mar; 125(3):392-8. PubMed ID: 16613342 [TBL] [Abstract][Full Text] [Related]
26. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications. Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753 [TBL] [Abstract][Full Text] [Related]
27. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278 [No Abstract] [Full Text] [Related]
28. Underexpression of hepatocyte nuclear factor-1β in chromophobe renal cell carcinoma. Wang CC; Mao TL; Yang WC; Jeng YM Histopathology; 2013 Mar; 62(4):589-94. PubMed ID: 23237209 [TBL] [Abstract][Full Text] [Related]
29. Utility of immunohistochemical analysis of KAI1, epithelial-specific antigen, and epithelial-related antigen for distinction of chromophobe renal cell carcinoma, an eosinophilic variant from renal oncocytoma. Ohe C; Kuroda N; Takasu K; Senzaki H; Shikata N; Yamaguchi T; Miyasaka C; Nakano Y; Sakaida N; Uemura Y Med Mol Morphol; 2012 Jun; 45(2):98-104. PubMed ID: 22718295 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643 [TBL] [Abstract][Full Text] [Related]
31. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma? Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253 [TBL] [Abstract][Full Text] [Related]
32. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma. Osunkoya AO; Cohen C; Lawson D; Picken MM; Amin MB; Young AN Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195 [TBL] [Abstract][Full Text] [Related]
33. Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study. Al-Ahmadie HA; Alden D; Fine SW; Gopalan A; Touijer KA; Russo P; Reuter VE; Tickoo SK Am J Surg Pathol; 2011 Jul; 35(7):949-61. PubMed ID: 21677535 [TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical study of c-KIT (CD117) expression in renal cell carcinoma. Ahmed EA; Youssif ME J Egypt Natl Canc Inst; 2009 Jun; 21(2):121-32. PubMed ID: 21057563 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Pan CC; Chen PC; Chiang H Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361 [TBL] [Abstract][Full Text] [Related]
36. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases. Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617 [TBL] [Abstract][Full Text] [Related]
37. CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma. Sukov WR; Ketterling RP; Lager DJ; Carlson AW; Sinnwell JP; Chow GK; Jenkins RB; Cheville JC Hum Pathol; 2009 Sep; 40(9):1296-303. PubMed ID: 19386349 [TBL] [Abstract][Full Text] [Related]
38. Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: an automated tissue microarray study. Huang W; Kanehira K; Drew S; Pier T Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):12-7. PubMed ID: 18769342 [TBL] [Abstract][Full Text] [Related]
39. Hybrid chromophobe renal cell neoplasm. Mai KT; Dhamanaskar P; Belanger E; Stinson WA Pathol Res Pract; 2005; 201(5):385-9. PubMed ID: 16047948 [TBL] [Abstract][Full Text] [Related]
40. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant. Foix MP; Dunatov A; Martinek P; Mundó EC; Suster S; Sperga M; Lopez JI; Ulamec M; Bulimbasic S; Montiel DP; Alaghehbandan R; Peckova K; Pivovarcikova K; Ondrej D; Rotterova P; Skenderi F; Prochazkova K; Dusek M; Hora M; Michal M; Hes O Virchows Arch; 2016 Dec; 469(6):669-678. PubMed ID: 27631338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]